Management of subsequent pregnancy after antepartum stillbirth. A review

References

• Samueloff A, Xenakis EM, Berkus MD, Huff RW, Langer O. Recurrent stillbirth: significance and characteristics. J Reprod Med 1993;38:883–886.
   PubMed Web of Science ®Google Scholar
• Sharma PP, Salihu HM, Oyelese Y, Ananth CV, Kirby RS. Is a race a determinant of stillbirth recurrence? Obstet Gynaecol 2006;107:391–397.
   PubMed Web of Science ®Google Scholar
• Robson S, Chan A, Keane RJ, Luke CG. Subsequent birth outcomes after an unexplained stillbirth: preliminary population-based retrospective cohort study. Aust N Z J Obstet Gynaecol 2001;4:29–35.
   Google Scholar
• Onwude JL, Eisman V, Selo-Ojeme DO. Recurrent stillbirths: a matched case-control study of unexplained stillbirths at term. J Obstet Gynaecol 2006;26:205–207.
   PubMedGoogle Scholar
• Lurie S, Eldar I, Glezerman M, Sadan O. Pregnancy outcome after stillbirth. J Reprod Med 2007;52:289–292.
   PubMed Web of Science ®Google Scholar
• ACOG practice bulletin. No 102. Management of Stillbirth. Obstet Gynecol 2009 Mar;113(3):748–761.
   PubMedGoogle Scholar
• Black M, Shetty A, Bhattacharya S. Obstetric outcomes subsequent to intrauterine death in the first pregnancy. BJOG 2008;115:269–274.
   PubMed Web of Science ®Google Scholar
• Heinonen S, Kirkinen P. Pregnancy outcome after previous stillbirth resulting from causes other than maternal conditions and foetal abnormalities. Birth 2000;27:33–37.
   PubMed Web of Science ®Google Scholar
• Donald J. Dudley, MD. Diabetic-associated stillbirth: incidence, pathophysiology, and prevention. Clin Perinatol 2007;34:611–626.
   PubMedGoogle Scholar
• Michael P. Nageotte MD. Antenatal testing: diabetes mellitus. Semin Perinatol 2008;32:269–270.
   PubMedGoogle Scholar
• Brecher A, Tharakan T, Williams A, Baxi L. Perinatal mortality in diabetic patients undergoing antepartum foetal evaluation: a case–control study. J Matern Foetal Neonatal Med 2002;12:423–427.
   PubMedGoogle Scholar
• Bracero LA, Figueroa R, Byrnr DW. Comparison of umbilical Doppler velocimetry, nonstress testing, and biophysical profile in pregnancies complicated by diabetes. J Ultrasound Med 1996;15:301–308.
   PubMed Web of Science ®Google Scholar
• Bracero LA, Haberman S, Byrne DW. Maternal glycemic control and umbilical artery doppler velocimetry. J Matern Neonatal Med 2002;12:342–348.
   PubMedGoogle Scholar
• Hawkins JS, Brian MC. Labor and delivery management for women with diabetes. Obstet Gynecol Clin N Am 2007;34:323–334.
   PubMedGoogle Scholar
• Alfirevic Z, Devane D, Gyte GM. Continuous cardiotography (CTG) as a form of electronic foetal monitoring for foetal assessment during labor. Cochrane Database Syst Rev 2006;3: CD006066.
   Google Scholar
• Barton JR, Sibai BM. Prediction and prevention of recurrent preeclampsia. Obstet and Gynaecol 2008;112:359–372.
   PubMed Web of Science ®Google Scholar
• Papageorghiou AT, Yu CK, Cicero S, Bower S, Nicolaides KH. Second-trimester uterine artery Doppler screening in unselected population: rewiev. J Maternal Foetal Neonatal Med 2002;12:78–88.
   PubMedGoogle Scholar
• Allen V, Joseph K, Murphy K, Magee L, Ohlsson A. The effect of hypertensive disorders in pregnancy on small for gestational age and stillbirth: a population based study. BMC Pregnancy and Childbirth 2004;4:17.
   PubMedGoogle Scholar
• Korteweg FJ, Gordijn SJ, Timmer A, Holm JP, Ravisé JM, Erwich JJ. A placental cause of intra-uterine foetal death depends on the perinatal mortality classification system used. Placenta 2008;29:71–80.
   PubMed Web of Science ®Google Scholar
• Facchinetti F, Marozio L, Frusca T, Grandone E, Venturini P, Tiscia GL, Zatti S, Benedetto C. Maternal thrombophilia and the risk of recurrence of preeclampsia. Am J Obstet Gynecol 2009 Jan200(1):46.e1–5. Epub 2008 Oct 9.
   Google Scholar
• Makrides M, Duley L, Olsen SF. Marine oil, and other prostaglandin precursor, supplementation for pregnancy uncomplicated by preeclampsia or intrauterine growth restriction (Review). The Cochrane library 2007, Issue 2: 2006 Jul 19;3:CD003402.
   Google Scholar
• Rumbold A, Crowther CA. Vitamin E supplementation in pregnancy (Review). The Cochrane library 2007. Issue 2: 2005 Apr 18;(2):CD004069.
   Google Scholar
• Rumbold A, Crowther CA. Vitamin C supplementation in pregnancy (Review). The Cochrane library 2007. Issue 2: 2005 Apr 18;(2):CD004072.
   Google Scholar
• Hofmeyr GJ, Atallah AN, Duley L. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems (Review). Cochrane library 2007. Issue 2: 2006 Jul 19;3:CD001059
   Google Scholar
• Abalos E, Duley L, Steyn DW, Henderson-Smart DJ. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev 2007;1: CD002252.
   Google Scholar
• Menezes EV, Yakoob MY, Soomro T, Haws RA, Darmstadt GL, Bhutta ZA. Reducing Stillbirth: prevention and management of medical disorders and infections during pregnancy. BMC Pregnancy Childbirth 2009;9 (Suppl 1):S4. 1–49.
   Google Scholar
• Duley L, Henderson-Smart DJ, Meher S, King JF. Antiplatelet agents for preventing pre-eclampsia and its complications (Review). The Cochrane library 2008. Issue 4: 2007 Apr 18;(2):CD004659.
   Google Scholar
• Coomarasamy A, Honest H, Papaioannou S, Gee H, Khan KS. Aspirin for prevention of preeclampsia in women with historical risk factors: a systematic review. Obstet Gynecol 2003;101:1319–1332.
   PubMed Web of Science ®Google Scholar
• Rey E, Garneau P, David M, Gauthier R, Leduc L, Michon N, Morin F, Demers C, Kahn SR, Magee LA, et al Dalteparin for the prevention of recurrence of placental-mediated complications of pregnancy in women without thrombophilia: a pilot randomized controlled trial. J Thromb Haemost 2009;7:58–64.
   PubMed Web of Science ®Google Scholar
• Derksen RH, De Groot PG. The obstetric antiphospholipid syndrome. J Reproductive Immunology 2008;77:41–50.
   PubMedGoogle Scholar
• De Groot PG, Derksen RH. The antiphospholipid syndrome: clinical characteristics, laboratory features and pathogenesis. Curr Opin Infect Dis 2005;18:205–210.
   PubMedGoogle Scholar
• Derksen RH, Khamashta M, Branch DW. Management of the obstetric antiphospholipid syndrome. Arthritis Rheum 2004;50:1028–1039.
   PubMed Web of Science ®Google Scholar
• Frank R, Witter MD. Management of the high risk lupus pregnant patient. Rheum Dis Clin N Am 2007;33: 253–265.
   PubMedGoogle Scholar
• Tulppala M, Marttunen M, Soderstrom-Anttila V, Foudila T, Ylikorkala O. Low-dose aspirin in prevention of miscarriage in women with unexplained or autoimmune related recurrent miscarriage: effect on prostacyclin and thromboxane A2 production. Hum Reprod 1997;12:1567–1572.
   PubMed Web of Science ®Google Scholar
• Laskin CA, Bombardier C, Hannah ME, Mandel Fp, Ritchie JW, Farewell V, et al Prednisone and aspirin in women with autoantibodies and unexplained recurrent foetal loss. N Engl J Med 1997;337:148–153.
   PubMed Web of Science ®Google Scholar
• Pattison NS, Chamley LW, Birdsall M, Zanderigo AM, Liddell HS, McDougall J. Does aspirin have a role in improving pregnancy outcome for women with the antiphospholipid syndrome? A randomized controlled trial. Am J Obstet Gynecol 2000;183:1008–1012.
   PubMed Web of Science ®Google Scholar
• Cowchock S, Reece EA. Do low-risk pregnant women with antiphospholipid antibodies need to be treated? Am J Obstet Gynecol 1997;176:1099–1100.
   PubMed Web of Science ®Google Scholar
• Rai R, Cohen H, Dave M, Regan L. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). Br Med J 1997;314 253–257.
   PubMed Web of Science ®Google Scholar
• Lockwood CJ. Heritable coagulopathies in pregnancy. Obstet Gynaecol Surv 1999;54:754–765.
   PubMedGoogle Scholar
• Rey E, Kahn SR, David M, Shrier I. Thrombophilic disorders and foetal loss: a meta-analysis. Lancet 2003;361: 901–908.
   PubMed Web of Science ®Google Scholar
• Dizon-Townson D, Miller C, Sibai C, Spong CY, Thom E, Wendel G. The relationship of the Factor V Leiden mutation and pregnancy autcomes for mother and foetus. Obstet Gynaecol 2005;106:517–524.
   PubMed Web of Science ®Google Scholar
• Gonen R, Lavi N, Attias D, Schliamser L, Borochowitz Z, Toubi E, Ohel G. Absence of association of inerithed thrombophylia with unexplained third-trimester intrauterine foetal death. Am J Obstet Gynaecol 2005;192:742–746.
   PubMedGoogle Scholar
• Gris JC, Mercier E, Quere I, Lavigne-Lissalde G, Cochery-Nouvellon E, Hoffet M et al Low-molecular-weight heparin versus low dose aspirin in women with one foetal loss and a constitutional thrombophylic disorder. Blood 2004;103:3695–3699.
   PubMed Web of Science ®Google Scholar
• Brenner B, Hoffman R, Blumenfeld Z, Weiner Z, Younis JS. Gestational outcome in thrombophilic women with recurrent pregnancy loss treated by enoxaparin. Thromb Haemost 2000;83:693–697.
   PubMed Web of Science ®Google Scholar
• Bloomenthal D, Von Dadelszen P, Liston R, Magee L, Tsang P. The effect of factor V Leiden carriage on maternal and foetal health. CMAJ2002;167:48–54.
   PubMed Web of Science ®Google Scholar
• Duhl AJ, Paidas MJ, Ural SH, et al Antithrombotic therapy and pregnancy: consensus report and recommendations for prevention and treatment of venous thromboembolism and adverse pregnancy outcome. Am J Obstet Gynecol 2007;197:457.e1–457.e21.
   Web of Science ®Google Scholar
• Froen JF, Gardosi J, Thurmann A, Francis A, Stray-Pedersen B. Restricted foetal growth in sudden intrauterine unexplained death. Acta Obstet Gynecol Scand 2004;83:801–807.
   PubMed Web of Science ®Google Scholar
• Reddy U. Prediction and prevention of recurrent stillbirth. Obstet Gynaecol 2007;110:1151–1164.
   PubMed Web of Science ®Google Scholar
• American College of Obstetricians and Gynaecologists. Intrautherine growth restriction. ACOG Pract Bull 12, 2000.
   Google Scholar
• The GRIT Study Group. A randomized trial of timed delivery for the compromised preterm foetus: short term outcomes and Bayesian interpretation. BJOG 2003;110:27–32.
   PubMed Web of Science ®Google Scholar
• Saastad E, Vangen S, Frø´en JF. Suboptimal care in stillbirth – a retrospective audit study. Acta Obstet Gynaecol Scand 2007;86:444–450.
   PubMed Web of Science ®Google Scholar
• Stephansson O, Dickman PW, Johansson AL, Cnattingius S. The influence of socioeconomic status on stillbirth risk in Sweden. Int Epidemiol 2001;30:1296–1301.
   PubMed Web of Science ®Google Scholar
• Guildea ZE, Fone DL, Dunstan FD, Sibert JR, Cartlidge PH, Social deprivation and the causes of stillbirth and infant mortality. Arch Dis Child 2001;84:307–310.
   PubMed Web of Science ®Google Scholar
• Confidential enquiry into stillbirth and death in infancy. Enquiry comments on 422 stillbirth occurring 1996–97. 8th Annual report. 1999 http://www.cemach.org.uk.
   Google Scholar
• La nascita in Emilia-Romagna. 5 Rapporto sui dati del Certificato di Assistenza al Parto (CedAP) – Anno 2007. Novembre 2008. Giunta Regionale. Direzione Generale Sanità e Politiche Sociali.
   Google Scholar
• Chu SY, Kim SY, Lau JL, Sychmid CH, Dietz PM, Callaghan WM, Curtis KM. Maternal obesity and risk of stillbirth: a metaanalysis. Review. Am J Obstet Gynaecol 2007:223–228.
   PubMedGoogle Scholar
• Stephansson O, Dickman PW, Johansson A, Cnattingius S. Maternal weight, pregnancy weight gain, and the risk of antepartum stillbirth. Am J Obstet Gynecol 2001;184:463–469.
   PubMed Web of Science ®Google Scholar
• Cnattingius S, Lambe M. Trends in smoking and overweight during pregnancy: prevalence, risks of pregnancy complications, and adverse pregnancy outcomes. Semin Perinatol 2002;26:286–295.
   PubMed Web of Science ®Google Scholar
• Wisborg K, Henriksen TB, Secher NJ. A prospective intervention study of stopping smoking in pregnancy in a routine antenatal care setting. Br J Obstet Gynaecol. 1998;105:1171–1176.
   PubMedGoogle Scholar
• Odegrd RA, Vatten LI, Nilsen ST, Salvesen KA, Austgulen R. Risk factors and clinical manifestations of pre-eclampsia. BJOG 2000;107:1410–1416.
   PubMedGoogle Scholar
• Ananth CV, Smulian JC, Demissie K, Vintzileos AM, Knuppel RA. Placental abruption among singleton and twin births in the United States: risk factor profiles. Am J Epidemiol 200;153:771–778.
   Google Scholar
• Cnattingius S. The epidemiology of smoking during pregnancy: smoking prevalence, maternal characteristics, and pregnancy outcomes. Nicotine Tob Res. 2004;S125–S140.
   Google Scholar
• Grosso LM, Bracken MB. Caffeine metabolism, genetics and perinatal outcomes: a review of exposure assessment considerations during pregnancy. Ann Epidemiol 2005;15:460–466.
   PubMed Web of Science ®Google Scholar
• Bech BH, Autrup H, Nohr EA, Henriksen TB, Olsen J. Stillbirth and slow metabolizers of caffeine: comparison by genotyper. Int J Epidemiol 2006 Aug;35(4):948–953.
   PubMedGoogle Scholar
• Kesmodel U, Wisborg K, Olsen SF, Henriksen TB, Secher NJ. Moderate alcohol intake during pregnancy and the risk of stillbirth and death in the first year of life. Am J Epidemiol 2002;155:305–312.
   PubMed Web of Science ®Google Scholar
• Robson S, Thompson J, Ellwood D. Obstetric management of the next pregnancy after an unexplained stillbirth: an anonymous postalsurvey of Australian obstetricians. Aust N Z J Obstetrics Gynaecol 2006;46:278–281.
   PubMed Web of Science ®Google Scholar
• Moore TR, Piacquadio K. A prospective evaluation of foetal movement screening to reduce the incidence of antepartum foetal death. Am J Obstet Gynaecol 1989;160:1075–1080.
   PubMed Web of Science ®Google Scholar
• Heazell AE, Froen JF. Methods of foetal movement counting and detection of foetal compromise. J Obstet Gynaecol 2008;28:147–154.
   PubMedGoogle Scholar
• Mangesi L, Hofmeyr GJ. Foetal movement counting for assessment of foetal wellbeing (Review). The Cochrane Library 2008: 2007 Jan 24;(1):CD004909.
   Google Scholar
• Smith GCS, Fretts RC. Stillbirth. Lancet 2007;370:1715–1725.
   PubMed Web of Science ®Google Scholar
• Neilson JP, Alfirevic Z. Doppler ultrasound for foetal assesment in high risk pregnancies. Cochrane Database Syst Rev 2000;2 CD000073.
   Google Scholar
• Smith GCS. Life-table analysis of the risk of perinattal death at term and post term in singleton pregnancies. Am J Obstet Gynaecol 2001;184:489–496.
   PubMed Web of Science ®Google Scholar